Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Grant/Award of 52,832 ELTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 52,832 | n/a |
| Feb 3, 2026 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 20,800 | n/a |
| Dec 10, 2025 | Elicio Therapeutics, Inc. (ELTX) | Exercise/Conversion | 362 | $1.6K |
| Feb 4, 2025 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 44,400 | n/a |
| Dec 18, 2024 | Elicio Therapeutics, Inc. (ELTX) | Exercise/Conversion | 381 | $1.7K |
| Oct 2, 2024 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 29,800 | n/a |
| Feb 5, 2024 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 29,800 | n/a |